Suppression of post-angioplasty restenosis with an Akt1 siRNA-embedded coronary stent in a rabbit model

被引:46
|
作者
Che, Hui-Lian [1 ,2 ,3 ]
Bae, In-Ho [3 ]
Lim, Kyung Seob [3 ]
Song, In Taek [4 ]
Lee, Haeshin [4 ]
Muthiah, Muthunarayanan [1 ,2 ]
Namgung, Ran [5 ]
Kim, Won Jong [5 ]
Kim, Dong-Gon [6 ]
Ahn, Youngkeun [3 ]
Jeong, Myung-Ho [3 ]
Park, In-Kyu [1 ,2 ,3 ]
机构
[1] Chonnam Natl Univ, Dept Biomed Sci, Sch Med, Kwangju 501746, South Korea
[2] Chonnam Natl Univ, Ctr Biomed Human Resources Project BK21, Sch Med, Kwangju 501746, South Korea
[3] Chonnam Natl Univ Hosp, Heart Res Ctr, Kwangju, South Korea
[4] Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea
[5] Pohang Univ Sci & Technol, Dept Chem, BK 21, Pohang 790784, South Korea
[6] MITech Co Ltd, Inst Intervent Med, Pyeongtaek 451864, South Korea
基金
新加坡国家研究基金会;
关键词
Akt1; siRNA; Disulfide cross-linked low molecular PEI; Hyaluronic acid (HA)-coated stent; Vascular smooth muscle cells; Restenosis; SMOOTH-MUSCLE-CELLS; HYALURONIC-ACID; GENE DELIVERY; CULTURE; SURFACE; VECTOR; DNA; POLYETHYLENIMINE; ANGIOPLASTY; COMPLEXES;
D O I
10.1016/j.biomaterials.2012.07.045
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Restenosis is the formation of blockages occurring at the site of angioplasty or stent placement. In order to avoid such blockages, the suppression of smooth muscle cells near the implanted stent is required. The Akt1 protein is known to be responsible for cellular proliferation, and specific inhibition of Akt1 gene expression results in the retardation of cell growth. To take advantage of these benefits, we developed a new delivery technique for Akt1 siRNA nanoparticles from a hyaluronic acid (HA)-coated stent surface. For this purpose, the disulfide cross-linked low molecular polyethyleneimine (PEI) (ssPEI) was used as a gene delivery carrier because disulfide bonds are stable in an oxidative extracellular environment but degrade rapidly in reductive intracellular environments. In this study, Alct1 siRNA showed efficient ionic interaction with the ssPEI carrier, which was confirmed by polyacrylamide gel electrophoresis. Akt1 siRNA/ssPEI nanoparticles (ASNs) were immobilized on the HA-coated stent surface and exhibited stable binding and localization, followed by time-dependent sustained release for intracellular uptake. Cellular viability on the nanoparticle-immobilized surface was assessed using A10 vascular smooth muscle cells, and the results revealed that immobilized ASNs exhibited negligible cytotoxicity against the adhering A10 cells. Transfection efficiency was quantified using a luciferase assay; the transgene expression of Akt1 suppression through the delivered Akt1 siRNA was measured using RT-PCR and western blot, demonstrating higher gene silencing efficiency when compared to other carriers. ASN coated on HA stents were deployed in the balloon-injured external iliac artery in rabbits in vivo. It was shown that the Akt1 released from the stent suppressed the growth of the smooth muscle at the peri-stent implantation area, resulting in the prevention of restenosis in the post-implantation phase. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:8548 / 8556
页数:9
相关论文
共 2 条
  • [1] Therapeutic Effect of Akt1 siRNA Nanoparticle Eluting Coronary Stent on Suppression of Post-Angioplasty Restenosis
    Che, Hui-Lian
    Bae, In-Ho
    Lim, Kyung Seob
    Song, In Taek
    Lee, Haeshin
    Lee, Duhwan
    Kim, Won Jong
    Jeong, Myung-Ho
    Park, In-Kyu
    Ahn, Youngkeun
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2016, 12 (06) : 1211 - 1222
  • [2] Novel Fabrication of MicroRNA Nanoparticle-Coated Coronary Stent for Prevention of Post-Angioplasty Restenosis
    Che, Hui-Lian
    Bae, In-Ho
    Lim, Kyung Seob
    Uthaman, Saji
    Song, In Taek
    Lee, Haeshin
    Lee, Duhwan
    Kim, Won Jong
    Ahn, Youngkeun
    Park, In-Kyu
    Jeong, Myung-Ho
    KOREAN CIRCULATION JOURNAL, 2016, 46 (01) : 23 - 32